Akari Therapeutics PLC (NASDAQ:AKTX)

1.84
Delayed Data
As of 3:59pm ET
 -0.07 / -3.66%
Today’s Change
1.70
Today|||52-Week Range
11.95
-57.51%
Year-to-Date
No recent news for Akari Therapeutics PLC.

Today’s Trading

Previous close1.91
Today’s open1.94
Day’s range1.77 - 1.94
Volume34,795
Average volume (3 months)130,535
Market cap$29.4M
Data as of 3:59pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)-52.66%
Earnings growth (this year)+33.33%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.47

Competitors

 Today’s
change
Today’s
% change
KMPHKemPharm Inc+0.20+3.28%
EYPTEyepoint Pharmaceuti...-0.03-1.52%
ALTAltimmune Inc+0.04+8.79%
HSGXHistogenics Corp+0.07+3.21%
Data as of 4:00pm ET, 05/23/2018

Financials

Next reporting dateMay 30, 2018
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$0.00
Annual profit (last year)-$32.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Director, Chief Executive &
Operating Officer
Clive Stuart Richardson
Chief Financial Officer
Dov S. Elefant
Corporate headquarters
London, London & South East

Forecasts